液体推注治疗对早期实验性脓毒症肾损伤中肾脏灌注、氧合和功能的影响
本研究为干预性动物实验,在8只成年美利奴母羊中输注大肠埃希菌诱导早期脓毒症急性肾损伤。在脓毒症24、25、26小时分别给予液体推注治疗(15分钟内输注500 mL哈特曼溶液)。首次推注后30分钟血压、中心静脉压、心输出量、肾髓质氧分压、尿氧分压和肌酐清除率均升高,但后续两次推注对肌酐清除率无益,第三次推注后髓质氧合改善消失。动物潴留了总输注量的69%和钠的80%。结论提示液体推注的初期肾脏获益短暂且伴随显著液体潴留。
要点
- 在早期实验性脓毒症急性肾损伤中,首次液体推注(15分钟500 mL哈特曼溶液)后30分钟肌酐清除率增加120%±65%,但后续两次推注对肌酐清除率无益。
- 首次液体推注后30分钟肾髓质氧分压升高280%±90%,尿氧分压升高164%±80%,但第三次推注后髓质氧合改善消失。
- 脓毒症诱导后肾血流量增加46%±6%、皮质灌注增加25%±4%,但髓质灌注降低48%±5%、髓质氧分压降低56%±4%、尿氧分压降低54%±3%(p<0.01)。
- 研究动物潴留了总输注容量的69%和钠的80%,提示液体推注导致显著液体潴留。
- 整个研究期间尿氧分压与髓质氧分压显著相关。
适用人群与场景
- 成年美利奴母羊,通过输注大肠埃希菌诱导早期脓毒症急性肾损伤(n=8)。
处置流程与药物剂量
- 在脓毒症24、25、26小时分别给予液体推注治疗:15分钟内输注500 mL哈特曼溶液。
研究设计与关键结果
- 干预性动物实验:8只成年美利奴母羊输注大肠埃希菌诱导脓毒症急性肾损伤后,在24、25、26小时各给予一次液体推注(15分钟500 mL哈特曼溶液)。
- 脓毒症诱导后肌酐清除率下降、血浆肌酐升高,肾血流量增加46%±6%、皮质灌注增加25%±4%,但髓质灌注降低48%±5%、髓质氧分压降低56%±4%、尿氧分压降低54%±3%(p<0.01)。
- 首次液体推注后30分钟:血压升高6%±1%、中心静脉压升高245%±65%、心输出量增加11%±2%、髓质氧分压升高280%±90%、尿氧分压升高164%±80%、肌酐清除率增加120%±65%。
- 后续两次液体推注对肌酐清除率无有益效应;第三次液体推注后髓质氧合改善消失。
- 研究动物潴留总输注容量的69%和钠的80%;整个研究期间尿氧分压与髓质氧分压显著相关。
证据类型、等级与局限
- 证据类型:干预性动物实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在早期实验性脓毒症急性肾损伤中,液体推注治疗可短暂改善肾功能和髓质氧分压,尿氧分压可反映髓质氧分压变化;这些初期效应在4小时内消退,尽管又进行了两次液体推注,并导致显著液体潴留。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine the effects of fluid bolus therapy on systemic hemodynamics, renal blood flow, intrarenal perfusion and oxygenation, PO2, renal function, and fluid balance in experimental early septic acute kidney injury.
DESIGN: Interventional study.
SETTING: Research institute.
SUBJECTS: Adult Merino ewes.
INTERVENTIONS: Implantation of flow probes on the pulmonary and renal arteries and laser Doppler oxygen-sensing probes in the renal cortex, medulla, and within a bladder catheter in sheep. Infusion of Escherichia coli to induce septic acute kidney injury (n = 8). After 24, 25, and 26 hours of sepsis, fluid bolus therapy (500 mL of Hartmann's solution over 15 min) was administered.
MEASUREMENTS AND MAIN RESULTS: In conscious sheep, infusion of Escherichia coli decreased creatinine clearance and increased plasma creatinine, renal blood flow (+46% ± 6%) and cortical perfusion (+25% ± 4%), but medullary perfusion (-48% ± 5%), medullary PO2 (-56% ± 4%), and urinary PO2 (-54% ± 3%) decreased (p < 0.01). The first fluid bolus therapy increased blood pressure (+6% ± 1%), central venous pressure (+245% ± 65%), cardiac output (+11% ± 2%), medullary PO2 (+280% ± 90%), urinary PO2 (+164% ± 80%), and creatinine clearance (+120% ± 65%) at 30 minutes. The following two boluses had no beneficial effects on creatinine clearance. The improvement in medullary oxygenation dissipated following the third fluid bolus therapy. Study animals retained 69% of the total volume and 80% of sodium infused. Throughout the study, urinary PO2 correlated significantly with medullary PO2.
CONCLUSIONS: In early experimental septic acute kidney injury, fluid bolus therapy transiently improved renal function and medullary PO2, as also reflected by increased urinary PO2. These initial effects of fluid bolus therapy dissipated within 4 hours, despite two additional fluid boluses, and resulted in significant volume retention.
参考来源
- Lankadeva YR, Kosaka J, Iguchi N, et al. Effects of Fluid Bolus Therapy on Renal Perfusion, Oxygenation, and Function in Early Experimental Septic Kidney Injury. Crit Care Med. 2019. PMID: 30394921. doi:10.1097/CCM.0000000000003507
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。